X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Eyantra ventures Ltd.
BSE CODE: 512099   |   NSE CODE: NA   |   ISIN CODE : INE750G01019   |   02-Dec-2024 Hrs IST
BSE NSE
Rs. 963.90
0 ( 0% )
 
Prev Close ( Rs.)
963.90
Open ( Rs.)
963.90
 
High ( Rs.)
963.90
Low ( Rs.)
963.90
 
Volume
24
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
18-Nov-2024 20-Nov-2024 Preferential Issue of shares & Increase in Authorised Capital Inter alia, to transact the following business(es): 1. To Consider a proposal for Increase in Authorized Capital of the company and subsequent alteration to the Memorandum of Association of the Company; 2. To consider the proposal for issuance of equity shares on preferential basis and determination of the issue price, in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required; 3. To consider convening an Extraordinary General Meeting of the shareholders of the Company to obtain requisite approvals.
04-Nov-2024 11-Nov-2024 Preferential Issue of shares & Quarterly Results
19-Jul-2024 26-Jul-2024 Quarterly Results
10-May-2024 21-May-2024 Audited Results
17-Jan-2024 25-Jan-2024 Quarterly Results
02-Nov-2023 10-Nov-2023 Quarterly Results
31-Jul-2023 08-Aug-2023 Quarterly Results
21-Jun-2023 27-Jun-2023 Preferential Issue of shares & Inter alia, to consider and approve :- 1. Proposal for issuance of equity shares for cash and/ or for consideration other than cash by way of a preferential allotment and determination of the issue price, in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required; 2. To consider convening Extra-Ordinary General Meeting of the shareholders of the Company to obtain requisite approvals and; 3. Any other business with the permission of the chair, if any.
10-May-2023 18-May-2023 Audited Results
18-Jan-2023 27-Jan-2023 Quarterly Results
Page 1 of 10
PREV || NEXT